Advertisement

Topics

As Roche wades biosimilar waters, more competitors circle Herceptin

09:31 EDT 2 Aug 2017 | BioPharmaDive

The FDA accepted two additional filings for versions of the breast cancer biologic earlier this week.

Original Article: As Roche wades biosimilar waters, more competitors circle Herceptin

NEXT ARTICLE

More From BioPortfolio on "As Roche wades biosimilar waters, more competitors circle Herceptin"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...